CI:NYE-Cigna Corporation (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 203.89

Change

+1.43 (+0.71)%

Market Cap

USD 68.83B

Volume

1.71M

Avg Analyst Target

USD 281.62 (+38.12%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-24 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

-0.95 (-0.23%)

USD384.74B 26.95 17.67
CVS CVS Health Corporation

-0.15 (-0.18%)

USD110.75B 13.29 10.76
ANTM Anthem Inc

+1.03 (+0.27%)

USD92.72B 22.50 N/A
HUM Humana Inc

-2.54 (-0.63%)

USD51.59B 21.23 N/A
CNC Centene Corporation

+0.22 (+0.35%)

USD36.50B 51.31 13.79
MOH Molina Healthcare Inc

+4.90 (+1.73%)

USD16.51B 26.45 10.79
BHG Bright Health Group Inc.

-0.22 (-2.48%)

USD5.59B N/A N/A
GTS Triple-S Management Corporatio..

-0.20 (-0.57%)

USD0.83B 8.48 N/A

ETFs Containing CI

Symbol Name Weight Mer Price(Change) Market Cap
CVY Invesco Zacks Multi-Asset.. 0.00 % 0.94 %

-0.05 (-0.19%)

USD0.13B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.20 (-0.12%)

N/A
VGVL:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

N/A
UET0:XETRA UBS (Lux) Fund Solutions .. 0.00 % 0.00 %

-0.04 (-0.25%)

USD0.51B
UBUW:XETRA UBS (Irl) ETF Public Limi.. 0.00 % 0.35 %

-0.05 (-0.18%)

USD0.15B
UBUS:XETRA UBS (Irl) ETF Public Limi.. 0.00 % 0.25 %

+0.04 (+0.14%)

USD0.60B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.68 (+0.25%)

USD0.53B
SYB1:XETRA SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.30 (-0.18%)

USD0.06B
UEF0:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

-0.09 (-0.44%)

USD0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 0.00 % 0.35 %

+0.01 (+0.04%)

USD0.15B
UBUS:F UBS (Irl) ETF Public Limi.. 0.00 % 0.25 %

+0.11 (+0.44%)

USD0.60B
SYB1:F SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.89 (-0.97%)

USD0.39B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.74 (+0.27%)

USD0.53B
ESGL Invesco ESG Revenue ETF 0.00 % 0.40 %

N/A

USD0.03B
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.05 (+0.05%)

USD0.32B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.13 (+0.18%)

USD3.06M
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

N/A

USD0.01B
UC98:LSE UBS (Lux) Fund Solutions .. 0.00 % 0.20 %

-0.75 (-0.06%)

USD0.26B
UC96:LSE UBS (Irl) ETF Public Limi.. 0.00 % 0.25 %

N/A

USD0.60B
CGAA:CA CI First Asset Global Ass.. 0.00 % 0.90 %

N/A

USD0.02B
JAGG JPMorgan U.S. Aggregate B.. 0.00 % 0.07 %

-0.11 (-0.19%)

USD1.11B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD0.27B
HONR InsightShares Patriotic E.. 0.00 % 0.65 %

N/A

USD1.34M
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.38 %

-0.09 (-0.23%)

USD0.21B
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

+0.08 (+0.19%)

USD0.13B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

-1.53 (-0.58%)

USD1.18B
VMUS:XETRA VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

-0.01 (-0.02%)

USD9.71M

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.06% 25% F 23% F
Dividend Return 1.44% 80% B- 39% F
Total Return -0.62% 25% F 23% F
Trailing 12 Months  
Capital Gain 25.51% 38% F 46% F
Dividend Return 1.85% 80% B- 31% F
Total Return 27.36% 38% F 44% F
Trailing 5 Years  
Capital Gain 55.64% 25% F 66% D
Dividend Return 2.41% 20% F 7% F
Total Return 58.05% 25% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.28% 25% F 66% D
Dividend Return 0.14% 33% F 3% F
Total Return 11.42% 25% F 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 19.92% 75% C 57% F
Risk Adjusted Return 57.32% 38% F 64% D
Market Capitalization 68.83B 67% D+ 96% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 19.34 75% C 43% F
Price/Book Ratio 1.41 89% B+ 61% D-
Price / Cash Flow Ratio 6.65 67% D+ 56% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 1,696.80% 100% A+ 96% A
Return on Invested Capital 6.96% 44% F 65% D
Return on Assets 3.24% 25% F 58% F
Debt to Equity Ratio 58.70% 63% D 58% F
Technical Ratios  
Short Ratio 4.51 11% F 27% F
Short Percent 2.96% 11% F 52% F
Beta 0.88 38% F 65% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.